These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1355637

  • 1. Role of guanylate cyclase-cGMP systems in halothane-induced vasodilation in canine cerebral arteries.
    Eskinder H, Hillard CJ, Flynn N, Bosnjak ZJ, Kampine JP.
    Anesthesiology; 1992 Sep; 77(3):482-7. PubMed ID: 1355637
    [Abstract] [Full Text] [Related]

  • 2. Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase.
    Jing M, Ling GS, Bina S, Hart JL, Muldoon SM.
    Eur J Pharmacol; 1998 Jan 26; 342(2-3):217-24. PubMed ID: 9548389
    [Abstract] [Full Text] [Related]

  • 3. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA, Tichotsky A, Muro M, Spaeth JP, Le Cras TD, Rengasamy A.
    Anesthesiology; 1995 Oct 26; 83(4):823-34. PubMed ID: 7574063
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.
    Papapetropoulos A, Cziraki A, Rubin JW, Stone CD, Catravas JD.
    J Cell Physiol; 1996 May 26; 167(2):213-21. PubMed ID: 8613461
    [Abstract] [Full Text] [Related]

  • 7. LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation.
    Mülsch A, Lückhoff A, Pohl U, Busse R, Bassenge E.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul 26; 340(1):119-25. PubMed ID: 2552329
    [Abstract] [Full Text] [Related]

  • 8. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F, Waldman S, Molina C, Bennett B, Leitman D.
    Prog Clin Biol Res; 1987 Jul 26; 249():65-76. PubMed ID: 2890172
    [Abstract] [Full Text] [Related]

  • 9. Modulation of rabbit ventricular cell volume and Na+/K+/2Cl- cotransport by cGMP and atrial natriuretic factor.
    Clemo HF, Feher JJ, Baumgarten CM.
    J Gen Physiol; 1992 Jul 26; 100(1):89-114. PubMed ID: 1355106
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Halothane and the guanylate cyclase system.
    Nakamura K, Toda H, Hatano Y.
    Anesthesiology; 1993 Mar 26; 78(3):617-8. PubMed ID: 8096127
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of ethacrynic acid and cystamine on sodium nitroprusside-induced relaxation, cyclic GMP levels and guanylate cyclase activity in rat aorta.
    Rapoport RM, Murad F.
    Gen Pharmacol; 1988 Mar 26; 19(1):61-5. PubMed ID: 2894333
    [Abstract] [Full Text] [Related]

  • 14. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles.
    Ding KH, Abdel-Latif AA.
    Invest Ophthalmol Vis Sci; 1997 Nov 26; 38(12):2629-38. PubMed ID: 9375582
    [Abstract] [Full Text] [Related]

  • 15. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
    Fleming I, Julou-Schaeffer G, Gray GA, Parratt JR, Stoclet JC.
    Br J Pharmacol; 1991 May 26; 103(1):1047-52. PubMed ID: 1678981
    [Abstract] [Full Text] [Related]

  • 16. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
    Greenberg SS, Cantor E, Ho E, Walega M.
    J Pharmacol Exp Ther; 1991 Sep 26; 258(3):1061-71. PubMed ID: 1679847
    [Abstract] [Full Text] [Related]

  • 17. C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems.
    Wright RS, Wei CM, Kim CH, Kinoshita M, Matsuda Y, Aarhus LL, Burnett JC, Miller WL.
    J Am Coll Cardiol; 1996 Oct 26; 28(4):1031-8. PubMed ID: 8837586
    [Abstract] [Full Text] [Related]

  • 18. Preferential proximal coronary dilation by activators of guanylate cyclase in awake dogs.
    Chu A, Murray JJ, Lin CC, Russell M, Hagen PO, Cobb FR.
    Am J Physiol; 1990 Aug 26; 259(2 Pt 2):H340-5. PubMed ID: 1974738
    [Abstract] [Full Text] [Related]

  • 19. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.
    Winquist RJ, Faison EP, Waldman SA, Schwartz K, Murad F, Rapoport RM.
    Proc Natl Acad Sci U S A; 1984 Dec 26; 81(23):7661-4. PubMed ID: 6150486
    [Abstract] [Full Text] [Related]

  • 20. Prolonged exposure of canine coronary arteries to a nitric oxide donor desensitizes soluble guanylate cyclase.
    Sorajja P, Cable DG, Hamner CE, Schaff HV.
    J Surg Res; 2005 Jan 26; 123(1):82-8. PubMed ID: 15652954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.